Free Trial
NASDAQ:MOTS

Motus GI (MOTS) Stock Price, News & Analysis

Motus GI logo

About Motus GI Stock (NASDAQ:MOTS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1,000 shs
Average Volume
4,908 shs
Market Capitalization
$1,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

Receive MOTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter.

MOTS Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Motus GI Holdings Inc
See More Headlines

MOTS Stock Analysis - Frequently Asked Questions

Motus GI Holdings, Inc. (NASDAQ:MOTS) announced its quarterly earnings results on Friday, November, 12th. The company reported ($30.00) EPS for the quarter, meeting analysts' consensus estimates of ($30.00). The firm earned $0.14 million during the quarter, compared to the consensus estimate of $0.12 million.

Motus GI shares reverse split on the morning of Thursday, November 2nd 2023. The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Motus GI (MOTS) raised $21 million in an initial public offering (IPO) on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Motus GI investors own include Inovio Pharmaceuticals (INO), NIO (NIO), Tesla (TSLA), Bionano Genomics (BNGO), Acasti Pharma (ACST) and Pfizer (PFE).

Company Calendar

Last Earnings
11/12/2021
Today
5/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:MOTS
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$319,000.00
Price / Cash Flow
N/A
Book Value
$1.74 per share
Price / Book
N/A

Miscellaneous

Free Float
5,749,000
Market Cap
$1,000.00
Optionable
Not Optionable
Beta
0.92
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:MOTS) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners